Resolving inflammation: Could it prevent memory loss in Down syndrome and Alzheimer?

Has ONE DAMN THING been done with resolvins since they were first identified in 2002?

Has your stroke doctor and hospital done ONE DAMN THING to initiate further research? Or it is not their problem to solve?  You as a patient are responsible for finding and fixing your inflammation problems? Good to know that the stroke medical world has their head in the sand or up their ass doing nothing.  You fix inflammation and statins are no longer needed since cholesterol won't be picked out of the bloodstream and packed into plaque.  Which is why this approach will never see the light of day. Big Pharma will kill it.

 

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

October 2002

The latest here: 

Resolving inflammation: Could it prevent memory loss in Down syndrome and Alzheimer?

MedicalXpress Breaking News-and-Events | March 16, 2020

Individuals with Down syndrome are at a much greater risk of developing Alzheimer disease, with inflammation of the brain starting early in life and the risk of Alzheimer reaching nearly 80% by the age of 60.

The root cause of Alzheimer disease is unknown. However, its frequency in patients with Down syndrome suggests that targeting inflammation in preclinical models of that syndrome could be an attractive strategy for designing therapies to promote healthier aging.

Advertisement

In one such preclinical model of Down syndrome, administering specialized lipids, known as resolvins, reduced inflammation and prevented memory loss, according to a recent article in Glia.
The findings were reported by researchers at the Medical University of South Carolina (MUSC), the Center for Alzheimer's Research at the Karolinska Institute in Sweden and the Knoebel Institute for Healthy Aging at the University of Denver.